Corticobasal Syndrome (CBS) is a clinically defined movement disorder characterized by asymmetric parkinsonism, cortical sensory deficits, apraxia, and alien limb phenomenon. However, the underlying pathology in CBS is heterogeneous, and multiple clinical subtypes have been identified based on presenting features, disease progression, and pathological correlates.
The clinical subtypes of CBS reflect the variable distribution of tau pathology and other co-pathologies in the brain. Understanding these subtypes is critical for:
The motor-predominant subtype is the classic presentation of CBS:
| Feature | Description | Prevalence |
|---|---|---|
| Asymmetric rigidity | Marked rigidity on one side, often contralateral to affected hemisphere | 90-100% |
| Apraxia | Ideomotor apraxia, particularly of the upper limb | 70-80% |
| Myoclonus | Cortical myoclonus, stimulus-sensitive | 40-60% |
| Dystonia | Limb dystonia, often focal and asymmetric | 60-80% |
| Alien limb | Involuntary limb movements, typically posterior variant | 30-50% |
Motor-predominant CBS most commonly associates with:
This variant presents with predominant gait and axial symptoms:
| Feature | Description | Prevalence |
|---|---|---|
| Early gait freezing | Prominent gait hesitation and freezing, particularly in doorways | 80-90% |
| Axial rigidity | Prominent neck and trunk rigidity | 70-80% |
| Early falls | Falls within 1-2 years of onset | 60-70% |
| Vertical gaze palsy | Supranuclear gaze limitation, often early | 50-60% |
| Minimal limb apraxia | Less prominent than classic CBS | Variable |
CBS-PAGF shows significant overlap with Progressive Supranuclear Palsy (PSP):
CBS-PAGF can be challenging to distinguish from PSP, particularly PSP with predominant parkinsonism (PSP-P):
| Feature | CBS-PAGF | PSP-P |
|---|---|---|
| Asymmetry | Marked asymmetry early | Symmetric onset |
| Cortical signs | Apraxia, cortical sensory loss | Less prominent |
| Myoclonus | Common | Less common |
| MRI | Frontoparietal atrophy | Midbrain atrophy |
This subtype presents with prominent cognitive and cortical features:
| Feature | Description | Prevalence |
|---|---|---|
| Cortical sensory loss | Two-point discrimination deficits, asterognosis | 50-70% |
| Apraxia | Severe ideomotor apraxia, often bilateral eventually | 80-90% |
| Executive dysfunction | Frontal executive deficits early | 70-80% |
| Language disturbance | Non-fluent aphasia in some cases | 30-50% |
| Visuospatial dysfunction | Particularly when right hemisphere affected | 40-60% |
Cortical cognitive CBS shows:
This variant presents with prominent behavioral changes:
| Feature | Description | Prevalence |
|---|---|---|
| Apathy | Loss of motivation, reduced initiative | 70-80% |
| Disinhibition | Impulsive behaviors, inappropriate social conduct | 40-50% |
| Executive dysfunction | Severe frontal lobe executive deficits | 80-90% |
| Personality change | Altered behavior and interpersonal relationships | 50-60% |
| Cognitive inflexibility | Perseveration, set-shifting deficits | 60-70% |
Frontal behavioral CBS associates with:
This subtype overlaps significantly with behavioral variant Frontotemporal Dementia (bvFTD):
This distinct variant presents with speech or language symptoms before motor features:
| Feature | Description | Prevalence |
|---|---|---|
| Aphasia | Non-fluent or logopenic aphasia | 60-70% |
| Apraxia of speech | Motor speech disorder, impaired articulation | 50-60% |
| Motor symptoms | Develop months to years after speech onset | Variable |
| Agraphia | Writing difficulties | 40-50% |
| Letter-by-letter reading | Slow serial letter naming | 30-40% |
Speech/language-onset CBS typically shows:
Important to distinguish from:
Some patients presenting with CBS have underlying AD pathology:
| Feature | Description | Prevalence |
|---|---|---|
| Memory complaints | Prominent episodic memory deficits | 50-60% |
| Posterior cortical symptoms | Visuospatial deficits, simultanagnosia | 40-50% |
| Fluctuating cognition | Variable performance day-to-day | 30-40% |
| Delayed onset | Slower progression than pure CBS | Variable |
| Biomarker | CBS-AD Finding |
|---|---|
| Amyloid PET | Positive in 20-30% of CBS |
| CSF Aβ42 | Reduced (confirming AD) |
| CSF tau | Elevated, often higher than pure CBS |
| p-tau181 | Elevated, correlates with AD pathology |
A subset of CBS patients have concomitant Lewy body pathology:
| Feature | Description | Prevalence |
|---|---|---|
| RBD | REM sleep behavior disorder | 20-30% |
| Visual hallucinations | Often early, well-formed | 15-25% |
| Fluctuating cognition | Variable attention and alertness | 20-30% |
| Parkinsonism | May show more symmetric features | Variable |
| Subtype | Key Features | Primary Pathology | Prognosis |
|---|---|---|---|
| Motor-predominant | Asymmetric rigidity, apraxia, myoclonus | 4R tau (CBD) | Moderate progression |
| CBS-PAGF | Early gait freezing, falls | PSP-like tau | More rapid |
| Cortical Cognitive | Cortical sensory loss, severe apraxia | Cortical tau + TDP-43 | Variable |
| Frontal Behavioral | Apathy, disinhibition | Frontotemporal tau/TDP-43 | Variable |
| Speech/Language | Aphasia before motor | Left hemisphere tau | Variable |
| CBS-AD | Memory, posterior symptoms | AD pathology | Moderate |
| CBS-LB | RBD, hallucinations | Synuclein + tau | Variable |
Recognizing CBS subtypes guides:
| Subtype | Treatment Focus | Considerations |
|---|---|---|
| Motor-predominant | Dopaminergic, anti-myoclonus | Limited levodopa response |
| CBS-PAGF | Balance, gait training | Falls prevention |
| Cortical cognitive | Cognitive rehabilitation | Environmental modifications |
| Frontal behavioral | Behavioral approaches | Safety monitoring |
| Speech/language | Speech therapy | Augmentative communication |